Amiloidózis: vizsgálatok itt: Hongkong

1 trial · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Where

  Hong Kong

  Életkor

  18 év to 85 év

  People

  1750 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07052903 · EU 2024-519917-72-00